Solesence, Inc.
SLSN- Exchange
- Nasdaq
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0000883107
No open-market purchases or sales by Solesence, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $2.32M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 11, 2026, 1:11 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Mar 31, 2026 | Mar 26, 2025 | Mar 5, 2024 | Mar 29, 2023 | Mar 31, 2022 |
| Revenue | $62.1M | $52.3M | $37.3M | $37.3M | $29.5M |
| Cost of revenue | $45.0M | $39.3M | $29.5M | $29.0M | $20.8M |
| Gross profit | $17.1M | $13.1M | $7.83M | $8.36M | $8.69M |
| Research and development | $4.09M | $3.84M | $3.84M | $3.04M | $2.23M |
| Selling, general and administrative | $10.4M | $7.22M | $7.53M | $7.58M | $3.90M |
| Operating income | $2.59M | $2.00M | -$3.55M | -$2.26M | $2.56M |
| Interest expense | – | – | $838.0K | $382.0K | $1.15M |
| Income tax | $73.0K | $227.0K | $6.00K | -$17.0K | $37.0K |
| Net income | $2.81M | $1.10M | -$4.39M | -$2.62M | $2.32M |
| EPS, basic | $0.04 | $0.02 | $-0.09 | $-0.05 | $0.05 |
| EPS, diluted | $0.04 | $0.02 | $-0.09 | $-0.05 | $0.05 |
| Weighted shares, basic | 70.3M | 62.4M | 49.6M | 49.1M | 45.0M |
| Weighted shares, diluted | 72.6M | 65.0M | 49.6M | 49.1M | 47.0M |
| Margins and growth | |||||
| Gross margin | 27.5% | 24.9% | 21.0% | 22.4% | 29.5% |
| Operating margin | 4.2% | 3.8% | -9.5% | -6.1% | 8.7% |
| Net margin | 4.5% | 2.1% | -11.8% | -7.0% | 7.9% |
| Revenue growth, year over year | +18.6% | +40.4% | −0.1% | +26.6% | +72.1% |
| Net income growth, year over year | +155.6% | – | – | −213.1% | +134.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Mar 31, 2026 | Mar 26, 2025 | Mar 5, 2024 | Mar 29, 2023 | Mar 31, 2022 |
| Cash and equivalents | $1.29M | $1.41M | $1.72M | $2.19M | $657.0K |
| Accounts receivable | $6.84M | $4.87M | $3.47M | $4.73M | $3.94M |
| Inventory | $14.9M | $15.6M | $10.0M | $8.84M | $6.09M |
| Total current assets | $25.1M | $24.7M | $16.3M | $16.6M | $11.6M |
| Property, plant and equipment | $14.3M | $12.7M | $8.67M | $7.95M | $4.71M |
| Total assets | $46.4M | $45.4M | $32.9M | $33.6M | $28.4M |
| Accounts payable | $4.10M | $9.09M | $6.26M | $6.36M | $3.57M |
| Total current liabilities | $13.9M | $25.8M | $15.6M | $16.8M | $8.73M |
| Long-term debt | – | – | – | $1.00M | – |
| Shareholders' equity | $14.0M | $10.3M | $1.90M | $5.65M | $7.46M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Reported | Mar 31, 2026 | Mar 26, 2025 | Mar 5, 2024 | Mar 29, 2023 | Mar 31, 2022 |
| Operating cash flow | -$8.57M | $1.97M | -$2.01M | -$1.65M | $2.32M |
| Capital expenditures | – | $4.56M | $1.05M | $2.82M | $1.87M |
| Free cash flow | – | -$2.59M | -$3.06M | -$4.47M | $447.0K |
| Depreciation and amortization | $897.0K | $928.0K | $742.0K | $567.0K | $454.0K |
| Stock-based compensation | $575.0K | $725.0K | $773.0K | $625.0K | $160.0K |
| Investing cash flow | -$2.14M | -$4.56M | -$1.05M | -$2.82M | -$1.87M |
| Financing cash flow | $10.6M | $2.27M | $2.59M | $6.00M | -$747.0K |
| Net change in cash | -$121.0K | -$313.0K | -$464.0K | $1.53M | -$300.0K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.9% | 1.4% | 2.1% | 1.7% | 0.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 19, 2026 | 70.6M | +0.2% | SEC |
| May 12, 2026 | 70.6M | +0.8% | SEC |
| Mar 30, 2026 | 70.6M | +0.8% | SEC |
| Nov 12, 2025 | 70.5M | +0.8% | SEC |
| Aug 14, 2025 | 70.5M | +0.9% | SEC |
| May 12, 2025 | 70.1M | +27.8% | SEC |
| Mar 28, 2025 | 70.1M | +27.9% | SEC |
| Nov 12, 2024 | 70.0M | +41.0% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.